Aviva PLC Harmony Biosciences Holdings, Inc. Transaction History
Aviva PLC
- $36.8 Billion
- Q4 2024
A detailed history of Aviva PLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Aviva PLC holds 18,072 shares of HRMY stock, worth $624,568. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,072
Previous 17,386
3.95%
Holding current value
$624,568
Previous $694,000
10.52%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$229 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$202 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$164 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$78.8 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$54.6 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.04B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...